Search research articles
Contact Us
Filters
Showing results (131-140 of 185) with videos related to
Page
of 19
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)
|
April 13, 2004
Absence of sustained hyperlactatemia in HIV-infected patients with risk factors for mitochondrial toxicity
David A Wohl, Christopher D Pilcher, Scott Evans, et al.
AIDS Patient Care and Stds
|
November 1, 2017
Underutilization of Statins When Indicated in HIV-Seropositive and Seronegative Women
Jonathan V Todd, Stephen R Cole, David A Wohl, et al.
Plos Pathogens
|
April 18, 2024
Modeling the emergence of viral resistance for SARS-CoV-2 during treatment with an anti-spike monoclonal antibody
Tin Phan, Carolin Zitzmann, Kara W Chew, et al.
AIDS Research and Human Retroviruses
|
May 26, 2020
"My Death Will Not [Be] in Vain": Testimonials from Last Gift Rapid Research Autopsy Study Participants Living with HIV at the End of Life
Kelly E Perry, Karine Dubé, Susanna Concha-Garcia, et al.
The Journal of Infectious Diseases
|
August 31, 2023
Long COVID After Bamlanivimab Treatment
Teresa H Evering, Carlee B Moser, Nikolaus Jilg, et al.
Biorxiv : the Preprint Server for Biology
|
September 25, 2023
Modeling the emergence of viral resistance for SARS-CoV-2 during treatment with an anti-spike monoclonal antibody
Tin Phan, Carolin Zitzmann, Kara W Chew, et al.
The Journal of Infectious Diseases
|
August 31, 2023
Immune Status and SARS-CoV-2 Viral Dynamics
Yijia Li, Carlee Moser, Evgenia Aga, et al.
The Journal of Infectious Diseases
|
August 31, 2023
Statistical Challenges When Analyzing SARS-CoV-2 RNA Measurements Below the Assay Limit of Quantification in COVID-19 Clinical Trials
Carlee B Moser, Kara W Chew, Mark J Giganti, et al.
BMC Infectious Diseases
|
July 19, 2022
The prevalence of Post-Ebola Syndrome hearing loss, Sierra Leone
Samuel C Ficenec, Donald S Grant, Ibrahim Sumah, et al.
Pathogens & Immunity
|
May 15, 2024
Safety, Efficacy, and Pharmacokinetics of Combination SARS-CoV-2 Neutralizing Monoclonal Antibodies BMS-986414 (C135-LS) and BMS-986413 (C144-LS) Administered Subcutaneously in Non-Hospitalized Persons with COVID-19 in a Phase 2 Trial
Katya C Corado, Kara W Chew, Mark J Giganti, et al.
Page
of 19
Search research articles
Search
Showing results (131-140 of 185) with videos related to
Sort By:
Page
of 19
Journal of Acquired Immune Deficiency Syndromes (1999)
|
April 13, 2004
Absence of sustained hyperlactatemia in HIV-infected patients with risk factors for mitochondrial toxicity
David A Wohl, Christopher D Pilcher, Scott Evans, et al.
AIDS Patient Care and Stds
|
November 1, 2017
Underutilization of Statins When Indicated in HIV-Seropositive and Seronegative Women
Jonathan V Todd, Stephen R Cole, David A Wohl, et al.
Plos Pathogens
|
April 18, 2024
Modeling the emergence of viral resistance for SARS-CoV-2 during treatment with an anti-spike monoclonal antibody
Tin Phan, Carolin Zitzmann, Kara W Chew, et al.
AIDS Research and Human Retroviruses
|
May 26, 2020
"My Death Will Not [Be] in Vain": Testimonials from Last Gift Rapid Research Autopsy Study Participants Living with HIV at the End of Life
Kelly E Perry, Karine Dubé, Susanna Concha-Garcia, et al.
The Journal of Infectious Diseases
|
August 31, 2023
Long COVID After Bamlanivimab Treatment
Teresa H Evering, Carlee B Moser, Nikolaus Jilg, et al.
Biorxiv : the Preprint Server for Biology
|
September 25, 2023
Modeling the emergence of viral resistance for SARS-CoV-2 during treatment with an anti-spike monoclonal antibody
Tin Phan, Carolin Zitzmann, Kara W Chew, et al.
The Journal of Infectious Diseases
|
August 31, 2023
Immune Status and SARS-CoV-2 Viral Dynamics
Yijia Li, Carlee Moser, Evgenia Aga, et al.
The Journal of Infectious Diseases
|
August 31, 2023
Statistical Challenges When Analyzing SARS-CoV-2 RNA Measurements Below the Assay Limit of Quantification in COVID-19 Clinical Trials
Carlee B Moser, Kara W Chew, Mark J Giganti, et al.
BMC Infectious Diseases
|
July 19, 2022
The prevalence of Post-Ebola Syndrome hearing loss, Sierra Leone
Samuel C Ficenec, Donald S Grant, Ibrahim Sumah, et al.
Pathogens & Immunity
|
May 15, 2024
Safety, Efficacy, and Pharmacokinetics of Combination SARS-CoV-2 Neutralizing Monoclonal Antibodies BMS-986414 (C135-LS) and BMS-986413 (C144-LS) Administered Subcutaneously in Non-Hospitalized Persons with COVID-19 in a Phase 2 Trial
Katya C Corado, Kara W Chew, Mark J Giganti, et al.
Page
of 19